|1.||Sanders, Virginia M: 4 articles (12/2015 - 01/2010)|
|2.||Jones, Kathryn J: 4 articles (12/2015 - 01/2010)|
|3.||Diallo, Ibrahima: 4 articles (08/2014 - 11/2006)|
|4.||de Vathaire, Florent: 4 articles (08/2014 - 11/2006)|
|5.||Haddy, Nadia: 3 articles (08/2014 - 11/2006)|
|6.||Guérin, Sylvie: 3 articles (07/2009 - 11/2006)|
|7.||Brugières, Laurence: 2 articles (08/2014 - 07/2007)|
|8.||Adjadj, Elisabeth: 2 articles (08/2014 - 07/2009)|
|9.||Mesnard, Nichole A: 2 articles (07/2014 - 02/2010)|
|10.||Midttun, Øivind: 2 articles (08/2011 - 08/2011)|
09/01/2011 - "Hence, RCP-targeting via FMN may be an elegant way to render nanoparticles fluorescent and to increase the labeling efficacy of cancer and activated endothelial cells. "
08/01/2014 - "In a case-control study nested in a cohort of childhood cancer survivors, lymphoblastoid cell lines (LCLs) were established from blood samples collected from 94 cases (SMN) and 94 matched controls (FMN). "
08/28/2012 - "Here, we implemented a novel approach using a magnetic micromesh and biocompatible fluorescent magnetic nanoparticles (FMN) to magnetically enhance cancer targeting in living subjects. "
11/01/2006 - "No specific type of first malignant neoplasm (FMN) was found to lead to a higher risk of secondary leukaemia. "
11/15/2000 - "Our investigation was performed as a nested case-control study within a Nordic cohort of 25,120 patients younger than 20 years old at first malignant neoplasm (FMN) diagnosed in 1960 through 1987. "
|2.||Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy)
|4.||Facial Nerve Injuries
06/05/1999 - "ER were neither present nor induced with facial nerve injury or TP administration in either the FMN or Nu5. "
01/01/2000 - "In this study, to clarify the pathologic change in the FMN after axotomy and to determine the best time for surgery, facial motoneuronal death was investigated after facial nerve injury. "
06/05/1999 - "The recent discovery of transient estrogen receptor (ER) expression in the developing rat facial motor nucleus (FMN), coupled with the concept that regeneration may recapitulate development, has led to the hypothesis that facial nerve injury may transiently induce expression of ER in the adult hamster FMN or one of its chief afferents, the principal nucleus of the trigeminal nerve (Nu5). "
11/06/1995 - "Two days after facial nerve avulsion, increased NADPH-d activity was noticed in the facial motoneurons and in the endothelial lining of many dilated blood vessels in the facial motor nucleus (FMN). "
12/01/2000 - "Testosterone propionate (TP) administration at the time of facial nerve injury in the adult hamster augments the regenerative properties of the injured facial motoneurons (FMN), with the androgen receptor (AR) playing a key role in mediating the actions of TP on facial nerve regeneration. "
|5.||Critical Illness (Critically Ill)
11/11/2010 - "The relationship between plasma riboflavin, FMN and FAD was significantly perturbed in critical illness. "
11/11/2010 - "In the critically ill patients, plasma riboflavin was not significantly associated with either plasma FMN or FAD. "
11/11/2010 - "On admission, compared with the controls, critically ill patients had significantly higher plasma riboflavin and FMN concentrations (p<0.001) and lower median plasma FAD concentrations (p<0.001). "
11/11/2010 - "Riboflavin, FMN and FAD concentrations were measured, by HPLC, in plasma and red cells in healthy subjects (n=119) and in critically ill patients (n=125) on admission and on follow-up. "
11/11/2010 - "Relation between riboflavin, flavin mononucleotide and flavin adenine dinucleotide concentrations in plasma and red cells in patients with critical illness."
|2.||Cytochromes c (Cytochrome c)
|3.||thiamine pyrophosphate drug combination flavin mononucleotide cytochrome C
|4.||Flavin Mononucleotide (FMN)
|5.||Flavin-Adenine Dinucleotide (FAD)
|6.||Riboflavin (Vitamin B2)
|7.||Vitamin B 12 (Cyanocobalamin)
|8.||Folic Acid (Vitamin M)
|4.||Drug Therapy (Chemotherapy)